...
首页> 外文期刊>Journal of Molecular Structure >Mefloquine derivatives: Crystal structures and anti-tubercular activities of diphenyl[((R~*,S~*)-2,8-bis(trifluoromethyl) quinolin-4-yl)-piperidin-2-yl-methanolato-O,N]boron and (±)-erythro- mefloquinium tetraphenylborate solvates
【24h】

Mefloquine derivatives: Crystal structures and anti-tubercular activities of diphenyl[((R~*,S~*)-2,8-bis(trifluoromethyl) quinolin-4-yl)-piperidin-2-yl-methanolato-O,N]boron and (±)-erythro- mefloquinium tetraphenylborate solvates

机译:甲氟喹衍生物:二苯基[[((R〜*,S〜*)-2,8-双(三氟甲基)喹啉-4-基)-哌啶-2-基-甲醇-O,N]的晶体结构和抗结核活性硼和(±)-赤-异氟喹啉四苯基硼酸酯溶剂化物

获取原文
获取原文并翻译 | 示例
           

摘要

Thermolysis of (R~*,S~*)-(2-{[2,8- bis(trifluoromethyl)quinolin-4-yl](hydroxy)~methyl}piperidin-1-ium) tetraphenylborate, (±)-erythro-mefloquinium tetraphenylborate, 3, in solution or neat, provides the oxazaborolidine derivative, diphenyl[(R ~*,S~*)-(2,8-bis(trifluoromethyl)quinolin-4-yl)] piperidin-2-yl-methanolato-O,N]boron, 2. Crystal structures of solvates of 2 and 3 are reported. As shown by the 1H NMR spectrum, 2 undergoes a conformation equilibrium in solution. Both 2 and 3 exhibit important anti-tubercular activities as indicated by the minimum inhibitory concentrations (MIC) of 50 and 12.5 μg/ml, respectively, in in vitro assays against M. tuberculosis H37Rv ATTC 27294.
机译:(R〜*,S〜*)-(2-{[2,8-双(三氟甲基)喹啉-4-基](羟基)〜甲基}哌啶-1-基)四苯基硼酸酯的热解,(±)-赤-四氟甲磺酸四苯基硼酸酯溶液3或纯净溶液,提供恶唑硼烷衍生物二苯基[(R〜*,S〜*)-(2,8-双(三氟甲基)喹啉-4-基)]哌啶-2-基-甲醇-O,N]硼2。据报道2和3的溶剂化物的晶体结构。如1 H NMR光谱所示,2在溶液中经历构象平衡。在针对结核分枝杆菌H37Rv ATTC 27294的体外测定中,最小抑菌浓度(MIC)分别为50和12.5μg/ ml,2和3均显示出重要的抗结核活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号